Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: A new marker for disease activity

Rheumatology International

Volumn 20, Issue 5, 2001, Pages 192-196

  Peltomaa, R ^a   Paimela, L ^a   Harvey, S ^a   Helve, T ^a   Leirisalo Repo, M ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Early rheumatoid arthritis; YKL 40

Indexed keywords

PROTEIN YKL 40; SECRETORY PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOGRAPHY; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; BIOLOGICAL MARKERS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; JOINTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0034917476     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002960100115     Document Type: Article

References (23)

1. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid
2. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family
3. Chondrex: New marker of joint disease
4. Molecular markers of processes in cartilage in joint disease
5. Immunochemical markers of joint inflammation, skeletal damage and repair: Where are we now?
6. Established and new biochemical tools for diagnosis and monitoring of rheumatoid arthritis
7. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis
8. Serum hyaluronate level as predictor of radiologic progression in early rheumatoid arthritis
9. Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis
10. Type I collagen degradation product in serum of patients with early rheumatoid arthritis: Relationship to disease activity and radiological progression in a 3-year follow-up
11. Reevaluating the therapeutic approach to rheumatoid arthritis: The "sawtooth" strategy
12. Effect of age on the 3-year outcome in early rheumatoid arthritis
13. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
14. Clinical studies with an articular index to assessment of joint tenderness in patients with rheumatoid arthritis
15. Graphic representation of pain
16. Measurement of patients outcome in arthritis
17. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films
18. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis
19. Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint
20. Plasma YKL-40: A new potential marker of fibrosis in patients with alcoholic cirrhosis?
21. The relationship between serum levels of YKL-40 and disease progression in patients with early rheumatoid arthritis
22. Serum YKL-40 concentrations in patients with rheumatoid arthritis: Relation to disease activity
23. Serum YKL-40 reflects disease relapse after withdrawal of SAARD in patients with rheumatoid arthritis